Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma

Lignende værker

• Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer
  af: Gasiorowska, A., et al.
  Udgivet: (2015)
• Procoagulant Disorders in Patients with Newly Diagnosed Pancreatic Adenocarcinoma
  af: Talar-Wojnarowska, Renata, et al.
  Udgivet: (2020)
• The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor, Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis
  af: Gasiorowska, Anita, et al.
  Udgivet: (2010)
• Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes
  af: Włodarczyk, Barbara, et al.
  Udgivet: (2020)
• Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes
  af: Barbara Włodarczyk, et al.
  Udgivet: (2020-05-01)